Hypoglycemic Agents: all 3,927 studies that test it
Page 26 of 40. Open to participants first (294), then studies with results posted, then the rest; newest registration first within each.
- Humalog or Humulin for Intensive Insulin Therapy in Intensive Care UnitCompletedNCT02165566Phase 4
- A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human InsulinCompletedNCT02162407Phase 1
- Intensive Versus Nonintensive Insulin Therapy for Hyperglycemia After Traumatic Brain InjuryStatus unknownNCT02161055Phase 4
- Feasibility Study to Determine the Optimal Calibration Method for Glucose SensorsCompletedNCT02155023Not applicable
- Stereotactic Radiosurgery and Metformin in Patients With Borderline-Resectable or Locally-Advanced Pancreatic CancerCompletedNCT02153450Early Phase 1
- Treatment of Recurrent Brain Tumors: Metabolic Manipulation Combined With RadiotherapyStatus unknownNCT02149459Phase 1
- A Trial Investigating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered NNC0148-0287 (Insulin 287) in Subjects With Type 2 DiabetesCompletedNCT02148861Phase 1
- Vildagliptin vs. Glibenclamide in Endothelial Function in Type 2 Diabetes and HypertensionCompletedNCT02145611Phase 4
- Pilot Study of Clinician-supported Patient Self-management of Hospital Insulin TherapyWithdrawnNCT02144441Not applicable
- Efficacy and Safety of Mitiglinide vs Acarbose in Patients With Type 2 Diabetes MellitusCompletedNCT02143765Phase 4
- Study of Dabrafenib, Trametinib and Metformin for Melanoma PatientsWithdrawnNCT02143050Phase 1/2
- Glycemic Durability After Metformin FailureStatus unknownNCT02142309Phase 4
- Topiramate Trial for Compulsive BuyingCompletedNCT02138058Phase 2
- Study of the Effectiveness and Safety of SugarDown vs. Placebo in Type 2 Diabetic Subjects Treated With MetforminCompletedNCT02135549Not applicable
- A Study of Pioglitazone and Carboplatin in Patients With Advanced Solid TumorsCompletedNCT02133625Phase 1
- Regulation of Endogenous Glucose Production by Brain Insulin ActionCompletedNCT02131948Phase 1
- A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT02131246Phase 1
- A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of Repaglinide and CaffeineCompletedNCT02128321Phase 1
- Cardioprotective Effects of GLP-1 and Their MechanismsCompletedNCT02128022Phase 1
- Clinical Study to Investigate the Pharmacokinetics and Pharmacodynamics of Metformin in the ElderlyCompletedNCT02125305Phase 1
- Study of Chiglitazar Compare With Placebo in Type 2 Diabetes PatientsCompletedNCT02121717Phase 3
- Advanced Lung Cancer Treatment With Metformin and Chemo-RadiotherapyTerminatedNCT02115464Phase 2
- Relative Bioavailability of Multiple Oral Doses of BI 187004 and Metformin After Co-administration Compared to Multiple Oral Doses of BI 187004 Alone and Metformin Alone in Healthy Male SubjectsCompletedNCT02109679Phase 1
- Renal Effects of DPP-4 Inhibitor Linagliptin in Type 2 DiabetesCompletedNCT02106104Phase 4
- Validation of the Artificial Pancreas Diabeloop Algorithm in the HospitalCompletedNCT02101229Phase 2/3
- Effect of Linagliptin on Insulin Sensitivity and Pancreatic Beta Cell Function in Patients With Type 2 Diabetes MellitusStatus unknownNCT02097342Phase 4
- Safety Evaluation of Adverse Reactions in DiabetesCompletedNCT02092597Phase 4
- Oral Antidiabetic Agents in PregnancyStatus unknownNCT02091336Phase 4
- A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy SubjectsCompletedNCT02089451Phase 1
- DPP-4 Inhibition, Incretins and Islet FunctionCompletedNCT02089438Phase 4
- A Open-label, Single-dose, 2-Sequence, 2-Period, Crossover Study to Assess Safety and Pharmacokinetics of a Nateglinide/Metformin HCl Combined Tablet Compared With a Nateglinide 120 mg Tablet and Metformin HCl 500 mg Tablet Under Fasting Conditions in Healthy Male SubjectsCompletedNCT02088918Phase 1
- Study of Clinical Response to Acute Metformin By Leveraging Evaluations During a Mixed Meal Tolerance Test for Exploring Glycemia and GeneticSActive, not recruitingNCT02087826Not applicable
- Targeting Pathways in Polycystic Ovary Syndrome (PCOS) Using Metformin (MET)CompletedNCT02086526Phase 1
- Pilot Study of Metformin in Head and Neck Squamous Cell Cancer and Its Effects on Stromal-epithelial Metabolic UncouplingCompletedNCT02083692Early Phase 1
- Glycaemic Control of Monthly LAPS-Exendin Versus Placebo in Subjects of Type 2 DiabetesCompletedNCT02081118Phase 2
- A Feasibility Study Looking at the Use of Glibenclamide and metfoRmin Versus stAndard Care in gEstational diabeteSCompletedNCT02080377Phase 3
- Effect of Linagliptin on Vascular Inflammation in Patients With Type 2 Diabetes MellitusTerminatedNCT02077309Phase 3
- Effect of LAPS-Exendin on Body Weight in Obese PopulationCompletedNCT02075281Phase 2
- A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual ComponentsCompletedNCT02073227Phase 1
- The Hypotensive Effect of Metformin in Hypertensive Patients.Status unknownNCT02072382Phase 4
- Evaluation of ETC-1002 vs Placebo in Patients Receiving Ongoing Statin TherapyCompletedNCT02072161Phase 2
- A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual Components in Healthy Fed ParticipantsCompletedNCT02071368Phase 1
- A Bioequivalence Study of the Fixed Dose Combination Tablets of Canagliflozin and Metformin Extended Release (XR) With Respect to the Individual ComponentsCompletedNCT02065752Phase 1
- Study to Evaluate the Safety and Efficacy of PAZ320 in Patients With Type 2 DiabetesCompletedNCT02060916Phase 2
- A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes MellitusStatus unknownNCT02059564Phase 1
- Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 DiabetesCompletedNCT02057172Phase 2
- BE Study of the Combinations of Gemigliptin 50mg and Metformin HCl Extended Release 1000mg in Comparison to Each Component Administered Alone.CompletedNCT02056600Phase 1
- Intensive Insulin Therapy With Tight Glycemic Control to Improve Outcomes After Endovascular Therapy for Acute Ischemic StrokeCompletedNCT02054429Phase 1
- The Role of Metformin and Colesevelam in Human GLP-1 SecretionCompletedNCT02050074Phase 4
- Metformin Hydrochloride, Carboplatin, and Paclitaxel in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT02050009Phase 1
- Locally Delivered 1% Metformin Gel in the Treatment of Intrabony Defects in Chronic PeriodontitisStatus unknownNCT02048761Phase 2
- Treatment With Continuous Sub-cutaneous Insulin Infusion Via a Portable Pump Versus Discontinuous Insulin Infusion Via Multiple-injections in Type 2 DiabetesTerminatedNCT02048189Phase 4
- Insulin Clamp Ancillary Study for Assessment of Insulin ResistanceCompletedNCT02045290Phase 3
- Endometrial Cancer Biomarker Changes Following Exposure to MetforminWithdrawnNCT02042495Phase 2
- Metformin for Brain Repair in Children With Cranial-Spinal Radiation for MedulloblastomaCompletedNCT02040376Phase 3
- Topiramate: Long-Term Maintenance of Weight Loss Induced by Low-Calorie Diet in Obese SubjectsTerminatedNCT02040311Phase 4
- Comparison of Metformin and Repaglinide Monotherapy in the Treatment of New Onset Type 2 Diabetes Mellitus in ChinaCompletedNCT02040246Phase 4
- fMRI and Ghlrein in Obesity and Binge Eating DisorderCompletedNCT02038712Not applicable
- PDE-4 Inhibitor Roflumilast and Polycystic Ovary SyndromeCompletedNCT02037672Phase 4
- Perioperative Insulin, GIK or GLP-1 Treatment in Diabetes MellitusCompletedNCT02036372Not applicable
- A Trial Investigating the Pharmacokinetic Properties of FIAsp in Children, Adolescents and Adults With Type 1 DiabetesCompletedNCT02035371Phase 1
- A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 DiabetesCompletedNCT02033239Phase 1
- A Double-blinded, Randomised, Two -Period Crossover Euglycemic Clamp Trial Investigating the Pharmacokinetics, Glucodynamics and Safety of BioChaperone Insulin Lispro and Insulin Lispro (Humalog®) in Subjects With Type 1 DiabetesCompletedNCT02029924Phase 1
- Metformin and Furosemide Drug-Drug Interaction StudyCompletedNCT02028689Phase 1
- Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor TherapyCompletedNCT02027753Phase 4
- Metformin and Pioglitazone Effects on Fetuin-A and Osteoprotegrin Concentrations in Type 2 Diabetes PatientsCompletedNCT02027103Not applicable
- Vaginal Administration of Metformin in PCOS Patients.Status unknownNCT02026869Early Phase 1
- Efficacy/Safety Study of Glimepiride to Type 2 Diabetes Patients Based on Metformin And Basal Insulin TreatmentCompletedNCT02026310Not applicable
- Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy SubjectsCompletedNCT02022254Phase 1
- L-citrulline and Metformin in Becker's Muscular DystrophyCompletedNCT02018731Phase 2
- Metformin in the Diastolic Dysfunction of Metabolic SyndromeCompletedNCT02017561Phase 2
- Off taRget Effects of Linagliptin monothErapy on Arterial Stiffness in Early DiabetesCompletedNCT02015299Phase 3
- Validation of Insulin Protocol for Glucocorticoid-induced Hyperglycemia in Diabetic Oncology PatientsCompletedNCT02012465Early Phase 1
- Metformin Combined With Gemcitabine as Adjuvant Therapy for Pancreatic Cancer After Curative ResectionCompletedNCT02005419Phase 2
- A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp in Geriatric and Younger Adult Subjects With Type 1 DiabetesCompletedNCT02003677Phase 1
- PCOS Treatment Using DLBS3233, Metformin, and Combination of BothCompletedNCT01999686Phase 3
- Metformin in Stage IV Lung AdenocarcinomaTerminatedNCT01997775Phase 2
- Prevention of Metabolic Syndrome and Increased Weight Using Metformin Concurrent to Androgen Deprivation Therapy and Radiotherapy for Locally Advanced Adenocarcinoma of the ProstateTerminatedNCT01996696Phase 2
- A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 DiabetesCompletedNCT01992588Phase 1
- Evaluating of Pharmacokinetic Profile of BCWP_C003 and Co-administration of Rosuvastatin and MetforminCompletedNCT01992211Phase 1
- A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni SyndromeCompletedNCT01981525Phase 1
- Pre-Surgical Trial of the Combination of Metformin and Atorvastatin in Newly Diagnosed Operable Breast CancerCompletedNCT01980823Early Phase 1
- Efficacy Safety and Tolerability of Multiple Doses of Oshadi Icp (Oshadi Oral Insulin) in Patients With Type 1 Diabetes Mellitus - Phase II Clinical StudyCompletedNCT01973920Phase 2
- Safety and Efficacy Study of Correcting Hyperglycemia in Patients With Diabetes Having Out-patient SurgeryWithdrawnNCT01971047Phase 4
- Treatment of Patients With Advanced Pancreatic Cancer After Gemcitabine Failure.CompletedNCT01971034Phase 2
- Efficacy and Safety Study of SP2086 in Combination With Metformin in Patients With Type 2 DiabetesCompletedNCT01969318Phase 2
- Metformin and Pioglitazone Effects on YKL-40 Concentrations in Type 2 Diabetes PatientsCompletedNCT01963663Not applicable
- Metformin's Effect on Glucagon-induced Glucose Production and Protein Metabolism.CompletedNCT01956929Phase 1
- Metformin Hydrochloride in Treating Patients With Pancreatic Cancer That Can be Removed by SurgeryWithdrawnNCT01954732Phase 1
- Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart DiseaseCompletedNCT01947790Phase 4
- Insulin by Jet-injection for Hyperglycemia in DiabetesCompletedNCT01947556Not applicable
- Linagliptin in Schizophrenia PatientsTerminatedNCT01943019Phase 1
- Metformin and 5-fluorouracil for Refractory Colorectal Cancer.CompletedNCT01941953Phase 2
- Evaluation of ETC-1002, Ezetimibe, and the Combination in Hypercholesterolemic PatientsCompletedNCT01941836Phase 2
- Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 and Metformin After Oral Administration in Healthy Male SubjectsCompletedNCT01941199Phase 1
- Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 DiabetesCompletedNCT01940965Phase 3
- A Study to Investigate the Glucose Lowering Effects of Dextromethorphan Alone or in Combination With Sitagliptin in Subjects With Type 2 Diabetes Mellitus (T2DM) After an Oral Glucose Tolerance TestCompletedNCT01936025Phase 2
- Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 DiabetesCompletedNCT01935804Phase 2
- A Trial Investigating the Pharmacokinetic Properties of FIAsp in Japanese Subjects With Type 1 DiabetesCompletedNCT01934712Phase 1
- Metformin Plus Irinotecan for Refractory Colorectal CancerStatus unknownNCT01930864Phase 2